Home/Filings/4/0001732716-25-000007
4//SEC Filing

Crocker Mary Jayne 4

Accession 0001732716-25-000007

CIK 0001341317other

Filed

Nov 16, 7:00 PM ET

Accepted

Nov 17, 5:34 PM ET

Size

12.1 KB

Accession

0001732716-25-000007

Insider Transaction Report

Form 4
Period: 2025-11-13
Crocker Mary Jayne
EVP & CHIEF STRATEGY OFFICER
Transactions
  • Sale

    Common Stock

    2025-11-13$17.04/sh4,080$69,524199,025 total
  • Exercise/Conversion

    Common Stock

    2025-11-17$7.47/sh+18,898$141,168217,923 total
  • Exercise/Conversion

    Option to buy

    2025-11-1718,89891,102 total
    Exercise: $7.47Exp: 2027-09-30Common Stock (18,898 underlying)
Holdings
  • Option to buy

    Exercise: $12.92Exp: 2029-12-06Common Stock (27,000 underlying)
    27,000
  • Option to buy

    Exercise: $17.50Exp: 2032-02-01Common Stock (20,000 underlying)
    20,000
Footnotes (5)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.01 to $17.10, inclusive. The reporting person undertakes to provide to Bridgewater Bancshares, Inc., any security holder of Bridgewater Bancshares, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price set forth in this footnote to this Form 4.
  • [F2]Options to buy granted under the 2017 Combined Incentive and Non-Statutory Stock Option Plan.
  • [F3]Options exercisable in 20% increments on the first five anniversaries of the date of the grant which was 10/1/2017.
  • [F4]Options exercisable in 25% increments on the first four anniversaries of the date of the grant which was 12/6/2019.
  • [F5]Options exercisable in 25% increments on the first four anniversaries of the date of the grant which was 2/1/2022.

Issuer

Bridgewater Bancshares Inc

CIK 0001341317

Entity typeother

Related Parties

1
  • filerCIK 0001732716

Filing Metadata

Form type
4
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 5:34 PM ET
Size
12.1 KB